Table 3.
Proportional Hazards Regression Models for Local Regional Failure
Gender (Male vs. Female[RL1]) | Marital Status (Unpartnered vs. Partnered[RL1]) | Race (Non-White vs. White[RL1]) | ||||
---|---|---|---|---|---|---|
Treatment Arm | Adjusted Hazard Ratio2 (95% CI1) | p-value | Adjusted Hazard Ratio2 (95% CI1) | p-value | Adjusted Hazard Ratio2 (95% CI1) | p-value |
9003: Arm 1 – SFX | 0.97 (0.68, 1.36) | 0.84 | 1.22 (0.89, 1.67) | 0.21 | 1.51 (1.10, 2.09) | 0.01 |
9003: Arm 2 – HFX | 0.97 (0.62, 1.51) | 0.88 | 1.28 (0.90, 1.82) | 0.17 | 0.98 (0.67, 1.42) | 0.90 |
9003: Arm 3 – AHFX-S | 1.28 (0.83, 1.97) | 0.27 | 1.09 (0.79, 1.50) | 0.60 | 1.20 (0.85, 1.68) | 0.30 |
9003: Arm 4 – AFX-C | 1.21 (0.76, 1.93) | 0.41 | 1.17 (0.83, 1.64) | 0.37 | 1.59 (0.76, 1.59) | 0.63 |
9111: Arm 1 – I+RT | 0.79 (0.48, 1.31) | 0.36 | 1.34 (0.86, 2.09) | 0.20 | 1.40 (0.87, 2.25) | 0.16 |
9111: Arm 2 – CRT | 2.56 (0.998, 6.59) | 0.052 | 1.31 (0.76, 2.27) | 0.34 | 1.51 (0.85, 2.69) | 0.16 |
9111: Arm 3 – RT Alone | 1.57 (0.87, 2.82) | 0.13 | 0.93 (0.61, 1.44) | 0.75 | 1.18 (0.75, 1.87) | 0.48 |
9703: Arm 1 – Cispl/5-FU | 0.94 (0.45, 1.97) | 0.86 | 1.84 (0.95, 3.55) | 0.07 | 1.25 (0.59, 2.67) | 0.57 |
9703: Arm 2 – Hydroxy/5-FU | 4.25 (0.995, 18.17) | 0.052 | 0.89 (0.48, 1.63) | 0.70 | 1.03 (0.52, 2.07) | 0.93 |
9703: Arm 3 – Cispl/Taxol | 0.74 (0.32, 1.70) | 0.48 | 1.24 (0.60, 2.58) | 0.56 | 0.98 (0.44, 2.17) | 0.96 |
| ||||||
Chi Square T.S. (Q) = 11.931 | Chi Square T.S. (Q) = 4.662 | Chi Square T.S. (Q) = 4.772 | ||||
p-value = 0.96 | p-value = 0.54 | p-value = 0.56 | ||||
| ||||||
Pooled HR3 | 1.10 (0.93, 1.30) | -- | 1.19 (1.04, 1.35) | -- | 1.22 (1.06, 1.41) | -- |
CI = Confidence Interval; RL = Reference Level
Adjusted for: T-stage (RL: T1-T3), N-stage (RL: N0-N1-N2a), KPS (RL: 60–80), primary site (RL: oropharynx; 9003 and 9703 only), and age (continuous).
This is a pooled estimate.